August 2017

2 APAC / August 2017 Editor’s Note , Welcome to the August edition of APAC Insider Magazine, providing the latest news and updates from across the Asia Pacific region. In this edition, we learn more about boutique internal brand led, alignment research and recruitment firm, Bricoleur Consulting when we invited General Manager, Nitya Rao-Perera to tell us more about the company. On 27th July, TESARO, Inc. and Takeda Pharmaceutical Company Limited announced an exclusive licensing agreement for the commercialisation and clinical development of niraparib, a novel poly ADP-ribose polymerase (PARP) inhibitor. Elsewhere in this issue, we profile GemVCare® (Gem stands for Genetic Evaluation & Management®), the first Hong Kong based genetic testing company that specialises in diabetes. I truly hope you thoroughly enjoy reading this insightful issue. Jessica Daykin, Editor Phone: +44 (0) 203 725 6842 Email: [email protected] Website: AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.